OTCPK:THRB.F

Stock Analysis Report

Executive Summary

Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Risks

  • Therma Bright is not covered by any analysts.

Share Price & News

How has Therma Bright's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:THRB.F

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

n/a

OTCPK:THRB.F

9.7%

US Medical Equipment

1.9%

US Market

No trading data on THRB.F.

No trading data on THRB.F.


Share holder returns

THRB.FIndustryMarket
7 Day0%1.5%0.8%
30 Dayn/a0.7%3.4%
90 Dayn/a2.4%2.1%
1 Yearn/a10.6%9.7%4.2%1.9%
3 Yearn/a70.2%65.0%46.7%37.2%
5 Yearn/a136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Therma Bright's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Therma Bright undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Therma Bright is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Therma Bright has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of THRB.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Therma Bright regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Therma Bright expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Therma Bright has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of THRB.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Therma Bright's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Therma Bright performed over the past 5 years?

-61.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Therma Bright does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Therma Bright's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Therma Bright's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Therma Bright has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Therma Bright has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Therma Bright improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Therma Bright's financial position?


Financial Position Analysis

Therma Bright's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Therma Bright's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Therma Bright has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Therma Bright's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Therma Bright has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Therma Bright has less than a year of cash runway based on current free cash flow.

Therma Bright has less than a year of cash runway if free cash flow continues to grow at historical rates of 119.6% each year.


Next Steps

Dividend

What is Therma Bright's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Therma Bright's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Therma Bright's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Therma Bright has not reported any payouts.

Unable to verify if Therma Bright's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Therma Bright has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Therma Bright's salary, the management and board of directors tenure and is there insider trading?

1.7yrs

Average board tenure


CEO

Rob Fia (49yo)

3.3yrs

Tenure

CA$30,000

Compensation

Mr. Roberto Fia, also known as Rob, serves as the Chairman of Therma Bright Inc. (formerly, The Jenex Corporation) and has been its Chief Executive Officer since May 18, 2016. Mr. Fia has been the Chief Ex ...


CEO Compensation Analysis

Rob's remuneration is lower than average for companies of similar size in United States of America.

Rob's compensation has been consistent with company performance over the past year, both up more than 20%.


Board Age and Tenure

1.7yrs

Average Tenure

67yo

Average Age

The average tenure for the Therma Bright board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyCA$5,21901 May 19
Roberto Fia
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares200,000
Max PriceCA$0.026

Ownership Breakdown


Management Team

  • Michael Mayo

    Director of Sales

    • Tenure: 0yrs
  • Rob Fia (49yo)

    Chairman

    • Tenure: 3.3yrs
    • Compensation: CA$30.00k
  • Vic Hugo (51yo)

    Chief Financial Officer

    • Tenure: 1.2yrs

Board Members

  • Bruno Maruzzo (67yo)

    Member of Advisory Board

    • Tenure: 1.3yrs
  • Gilbert Sharpe

    Member of Advisory Board

    • Tenure: 1.5yrs
  • Tim Peterson (71yo)

    Director

    • Tenure: 1.7yrs
  • Rob Fia (49yo)

    Chairman

    • Tenure: 3.3yrs
    • Compensation: CA$30.00k
  • Joe Heng

    Director

    • Tenure: 3.3yrs
  • Stephen McNeill

    Member of Advisory Board

    • Tenure: 1.7yrs
  • Leo Notidis

    Member of Advisory Board

    • Tenure: 1.7yrs
  • Joseph Galli

    Member of Advisory Board

    • Tenure: 1.7yrs
  • Michael Bosman

    Member of Advisory Board

    • Tenure: 1.7yrs
  • Steven Bennett

    Member of Advisory Board

    • Tenure: 1.3yrs

Company Information

Therma Bright Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Therma Bright Inc.
  • Ticker: THRB.F
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$4.094m
  • Listing Market Cap: CA$3.088m
  • Shares outstanding: 163.76m
  • Website: https://thermabright.com

Location

  • Therma Bright Inc.
  • 1173 Dundas Street East
  • Suite 132
  • Toronto
  • Ontario
  • M4M 3P1
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
THRMTSXV (TSX Venture Exchange)YesCommon SharesCACADJul 2001
JNXDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2001
THRB.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 2001

Biography

Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 00:47
End of Day Share Price2019/09/04 00:00
Earnings2019/04/30
Annual Earnings2018/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.